4/8
06:04 am
cbll
CeriBell (CBLL) had its "sell (d-)" rating reaffirmed by
Weiss Ratings.
Medium
Report
CeriBell (CBLL) had its "sell (d-)" rating reaffirmed by
Weiss Ratings.
4/2
09:50 am
cbll
Ceribell (CBLL) Rose 91% after Reporting Inline Financial Results [Yahoo! Finance]
Low
Report
Ceribell (CBLL) Rose 91% after Reporting Inline Financial Results [Yahoo! Finance]
3/2
10:38 am
cbll
Cautious Guidance Offsets Solid Q4 for CeriBell, Inc. (CBLL), Says Canaccord [Yahoo! Finance]
Low
Report
Cautious Guidance Offsets Solid Q4 for CeriBell, Inc. (CBLL), Says Canaccord [Yahoo! Finance]
2/26
02:42 am
cbll
CeriBell, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
Medium
Report
CeriBell, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
2/25
12:17 am
cbll
CeriBell Inc (CBLL) Q4 2025 Earnings Call Highlights: Revenue Surge and Market Expansion Amid ... [Yahoo! Finance]
Medium
Report
CeriBell Inc (CBLL) Q4 2025 Earnings Call Highlights: Revenue Surge and Market Expansion Amid ... [Yahoo! Finance]
2/24
04:05 pm
cbll
Ceribell Reports Fourth Quarter and Full Year 2025 Financial Results
Medium
Report
Ceribell Reports Fourth Quarter and Full Year 2025 Financial Results
2/23
07:42 am
cbll
CeriBell Inc (CBLL) Q4 2025: Everything You Need To Know Ahead Of Earnings [Yahoo! Finance]
Low
Report
CeriBell Inc (CBLL) Q4 2025: Everything You Need To Know Ahead Of Earnings [Yahoo! Finance]
2/18
04:05 pm
cbll
Ceribell to Participate in Upcoming March Investor Conferences
Low
Report
Ceribell to Participate in Upcoming March Investor Conferences
2/10
04:05 pm
cbll
Ceribell to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
Low
Report
Ceribell to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
1/28
08:41 am
cbll
CeriBell (NASDAQ:CBLL) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $30.00 price target on the stock.
Medium
Report
CeriBell (NASDAQ:CBLL) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $30.00 price target on the stock.
1/14
09:41 am
cbll
CeriBell Maps 2026 Growth at JPMorgan MedTech, Eyes Delirium and Stroke EEG Expansion [Yahoo! Finance]
Low
Report
CeriBell Maps 2026 Growth at JPMorgan MedTech, Eyes Delirium and Stroke EEG Expansion [Yahoo! Finance]